loading…
J3031 Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
BackJ3000Injection, streptomycin, up to 1 gm→J3010Injection, fentanyl citrate, 0.1 mg→J3030Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)→J3031Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)→J3032Injection, eptinezumab-jjmr, 1 mg→J3055Injection, talquetamab-tgvs, 0.25 mg→J3060Injection, taliglucerase alfa, 10 units→J3070Injection, pentazocine, 30 mg→J3090Injection, tedizolid phosphate, 1 mg→J3095Injection, telavancin, 10 mg→J3101Injection, tenecteplase, 1 mg→J3105Injection, terbutaline sulfate, up to 1 mg→J3110Injection, teriparatide, 10 mcg→J3111Injection, romosozumab-aqqg, 1 mg→J3121Injection, testosterone enanthate, 1 mg→J3145Injection, testosterone undecanoate, 1 mg→J3230Injection, chlorpromazine hcl, up to 50 mg→J3240Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial→J3241Injection, teprotumumab-trbw, 10 mg→J3243Injection, tigecycline, 1 mg→J3244Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg→J3245Injection, tildrakizumab, 1 mg→J3246Injection, tirofiban hcl, 0.25 mg→J3247Injection, secukinumab, intravenous, 1 mg→J3250Injection, trimethobenzamide hcl, up to 200 mg→J3260Injection, tobramycin sulfate, up to 80 mg→J3262Injection, tocilizumab, 1 mg→J3263Injection, toripalimab-tpzi, 1 mg→J3265Injection, torsemide, 10 mg/ml→J3268Injection, delafloxacin, 1 mg→J3285Injection, treprostinil, 1 mg→J3290Injection, tranexamic acid, 5 mg→J3291Injection, tranexamic acid in sodium chloride, 5 mg→J3299Injection, triamcinolone acetonide (xipere), 1 mg→J3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mg→J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg→J3302Injection, triamcinolone diacetate, per 5 mg→J3303Injection, triamcinolone hexacetonide, per 5 mg→J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg→J3315Injection, triptorelin pamoate, 3.75 mg→J3316Injection, triptorelin, extended-release, 3.75 mg→J3350Injection, urea, up to 40 gm→J3357Ustekinumab, for subcutaneous injection, 1 mg→J3358Ustekinumab, for intravenous injection, 1 mg→J3360Injection, diazepam, up to 5 mg→J3373Injection, vancomycin hydrochloride, 10 mg→J3374Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg→J3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg→J3376Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg→J3379Injection, valproate sodium, 5 mg→J3380Injection, vedolizumab, intravenous, 1 mg→J3385Injection, velaglucerase alfa, 100 units→J3386Injection, etuvetidigene autotemcel, per treatment→J3387Injection, elivaldogene autotemcel, per treatment→J3389Topical administration, prademagene zamikeracel, per treatment→J3391Injection, atidarsagene autotemcel, per treatment→J3392Injection, exagamglogene autotemcel, per treatment→J3393Injection, betibeglogene autotemcel, per treatment→J3394Injection, lovotibeglogene autotemcel, per treatment→J3396Injection, verteporfin, 0.1 mg→J3397Injection, vestronidase alfa-vjbk, 1 mg→J3398Injection, voretigene neparvovec-rzyl, 1 billion vector genomes→J3399Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes→J3401Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml→J3402Injection, remestemcel-l-rknd, per therapeutic dose→J3403Revakinagene taroretcel-lwey, per implant→J3404Injection, zopapogene imadenovec-drba suspension, per therapeutic dose→J3405Injection, onasemnogene abeparvovec-brve, per treatment→J3406Injection, omidubicel-onlv, per therapeutic dose→J3410Injection, hydroxyzine hcl, up to 25 mg→J3411Injection, thiamine hcl, 100 mg→J3415Injection, pyridoxine hcl, 100 mg→J3420Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg→J3424Injection, hydroxocobalamin, intravenous, 25 mg→J3425Injection, hydroxocobalamin, intramuscular, 10 mcg→J3430Injection, phytonadione (vitamin k), per 1 mg→J3465Injection, voriconazole, 10 mg→J3470Injection, hyaluronidase, up to 150 units→J3471Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)→J3472Injection, hyaluronidase, ovine, preservative free, per 1000 usp units→J3473Injection, hyaluronidase, recombinant, 1 usp unit→J3475Injection, magnesium sulfate, per 500 mg→J3480Injection, potassium chloride, per 2 meq→J3485Injection, zidovudine, 10 mg→J3486Injection, ziprasidone mesylate, 10 mg→J3489Injection, zoledronic acid, 1 mg→J3490Unclassified drugs→J3520Edetate disodium, per 150 mg→J3530Nasal vaccine inhalation→J3535Drug administered through a metered dose inhaler→J3570Laetrile, amygdalin, vitamin b17→J3590Unclassified biologics→J3591Unclassified drug or biological used for esrd on dialysis→
Procedure codeCODABLE
J3031
Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
- Part
- HCPCS Level II
- J
- Drugs Administered Other than Oral Method
- J3
- J3000–J3591
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.